S
SAB Biotherapeutics, Inc. (SABS)
NCM – Real Time Price. Currency in USD
3.80
-0.07 (-1.81%)
At close: Jun 26, 2026, 4:00 PM EDT
3.81
+0.01 (0.34%)
After-hours: Jun 26, 2026, 7:14 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.80
-0.07 (-1.81%)
At close: Jun 26, 2026, 4:00 PM EDT
3.81
+0.01 (0.34%)
After-hours: Jun 26, 2026, 7:14 PM EDT
This stock has a consensus price target of $10.86 based on the ratings of 15 analysts. The high is $16.00 and the low is $6.00.
| Target | Lowest Price Target | Consensus Price Target | Highest Price Target |
|---|---|---|---|
| Price | $ 6 | $ 10.86 | $ 16 |
| Change | 55.04% | 180.62% | 313.44% |
| Date | Upside/Downside | Analyst Firm | Price Target | Rating Change | Rating |
|---|---|---|---|---|---|
| 2026-06-24 | 242.11% | Barclays | $13 | Initiates Coverage On | Overweight |
| 2026-06-17 | 321.05% | Chardan Capital | $14 → $16 | Maintains | Buy |
| 2026-06-15 | 215.79% | Leerink Partners | $7 → $12 | Maintains | Outperform |
| 2026-06-15 | 163.16% | HC Wainwright & Co. | $10 → $10 | Reiterates | Buy |
| 2026-05-22 | 189.47% | Citigroup | $11 | Initiates Coverage On | Buy |